Imaging of Myeloma Bone Disease - Implications for Staging, Prognosis and Follow-up

Authors

  • Meletios A. Dimopoulos Departments of Clinical Therapeutics, Radiology and Nuclear Medicine, University of Athens School of Medicine, Athens, Greece
  • Lia A. Moulopoulos Departments of Clinical Therapeutics, Radiology and Nuclear Medicine, University of Athens School of Medicine, Athens, Greece
  • Ioannis Datseris Departments of Clinical Therapeutics, Radiology and Nuclear Medicine, University of Athens School of Medicine, Athens, Greece
  • Dimitra Gika Departments of Clinical Therapeutics, Radiology and Nuclear Medicine, University of Athens School of Medicine, Athens, Greece
  • Donna Weber Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
  • Kay Delasalle Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

DOI:

https://doi.org/10.1080/028418600750063578

Abstract

Among all imaging modalities, magnetic resonance imaging provides the most useful information about the accurate staging of solitary bone plasmacytoma, the prediction of progression of asymptomatic multiple myeloma and the prognosis of symptomatic multiple myeloma. Furthermore, magnetic resonance imaging contributes to the differential diagnosis of compression fractures in patients with myeloma and can be used for assessment of response to treatment.

Downloads

Download data is not yet available.

Downloads

Published

2000-01-01

How to Cite

Dimopoulos, M. A., Moulopoulos, L. A., Datseris, I., Gika, D., Weber, D., & Delasalle, K. (2000). Imaging of Myeloma Bone Disease - Implications for Staging, Prognosis and Follow-up. Acta Oncologica, 39(7), 823–827. https://doi.org/10.1080/028418600750063578

Issue

Vol. 39 No. 7 (2000): Acta Oncologica

Section

Articles